๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Desferrioxamine treatment reduces blood transfusion requirements in patients with myelodysplastic syndrome

โœ Scribed by P-D. Jensen; I.M. Jensen; J. Ellegaard


Book ID
113239536
Publisher
Elsevier Science
Year
1991
Tongue
English
Weight
157 KB
Volume
15
Category
Article
ISSN
0145-2126

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Red blood cell transfusions and iron ove
โœ Elias Jabbour; Hagop M. Kantarjian; Charles Koller; Ali Taher ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 185 KB ๐Ÿ‘ 2 views

## Abstract ## BACKGROUND Approximately 15,000 new cases of myelodysplastic syndromes (MDS) are expected in the United States each year. ## METHODS The mainstay for the management of myelodysplastic syndromes (MDS) is supportive therapy with red blood cell (RBC) transfusions to improve the patie